Columbus, OHNCT04633655Now EnrollingIRB Ready

Chemotherapy-induced Peripheral Neuropathy Clinical Trial in Columbus, OH

Access cutting-edge chemotherapy-induced peripheral neuropathy treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.

Sponsored by University of Milano Bicocca

Quick Self-Assessment

See if you qualify for this Columbus location

Preparing your pre-screening questions…

Expert Care in Columbus

Access chemotherapy-induced peripheral neuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chemotherapy-induced peripheral neuropathy treatment provided free

Apply for This Columbus Location

Check if you qualify for this chemotherapy-induced peripheral neuropathy clinical trial in Columbus, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbus

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbus site if eligible
  4. 4Begin participation

About This Chemotherapy-induced Peripheral Neuropathy Study in Columbus

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Sponsor: University of Milano Bicocca

Who Can Participate

Inclusion Criteria

Subjects must meet all of the following inclusion criteria to be eligible for enrolment into the study:
Subjects must be candidates for neurotoxic chemotherapy at doses expected to be potentially neurotoxic (a list of neurotoxic drugs is provided in Appendix 1).
Male and female subjects who are 18 years of age or older.
Subjects freely provide informed consent by signing and dating an informed consent form prior to study entry.
Subjects must be willing to complete all study-related activities and follow-up visits required by the protocol.
Subjects must have a Karnofsky performance score greater than or equal to 70.

Exclusion Criteria

Subjects presenting with any of the following will not be included in the study:
Poor prognosis, with high probability to be unable to complete the planned chemotherapy treatment.
Concomitant neurologic conditions (e.g., brain tumor, spinal or brain metastases) that would interfere or complicate the assessments.
Severe depression that in the opinion of the Investigator would complicate the assessments.
Chronic treatment with antiepileptic drugs, antidepressants and major analgesics, unless stable dosing and conditions have been reached for 3 months prior to entry.
Preventive interventions (e.g., antioxidants, cryotherapy, distal pressure).
Subjects who are currently receiving another medication other than antineoplastic chemotherapy drugs that has known potential to produce neurologic peripheral nerve toxicity (e.g. metronidazole, isoniazid, amiodarone, antiretroviral medications).
Subjects with any other condition, which, in the investigator's judgment, might decrease the chance of obtaining satisfactory data to achieve the objectives of the study.
Previous neurotoxic chemotherapy.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbus?

Yes, this clinical trial (NCT04633655) has an active research site in Columbus, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chemotherapy-induced Peripheral Neuropathy Treatment Options in Columbus, OH

If you're searching for chemotherapy-induced peripheral neuropathy treatment options in Columbus, OH, this clinical trial (NCT04633655) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chemotherapy-induced peripheral neuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chemotherapy-induced peripheral neuropathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Columbus, OH

See all pulmonary embolism clinical trials recruiting in Columbus — not just this study.

Browse Pulmonary Embolism Trials in Columbus →

Browse More Trials by Condition

Pulmonary Embolism TrialsNeuropathy TrialsRheumatoid Arthritis TrialsUlcerative Colitis TrialsPulmonary Hypertension TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Columbus?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbus, OH